*By Christian Smith* President Trump is opening himself up to allegations of obstruction by publicly dangling a pardon in front of his former campaign chairman Paul Manafort, "Proof of Collusion" author Seth Abramson told Cheddar on Monday. Prosecutors last week accused Manafort of violating his plea deal, claiming he lied to investigators during their investigation about the Trump campaign's ties to Russia. Manafort had already guilty to bank and tax fraud in order to avoid convictions on other charges as part of the agreement. The charge that he broke that deal by lying puts him in an "enormous amount of legal danger," said Abramson, a former criminal defense attorney. President Trump said last week that he had not discussed a pardon for Manafort, but that he would not "take it off the table." "It's not just that President Trump is refusing to rule out a pardon, he really has many times over the past few months publically dangled a pardon in front of Paul Manafort. And just today, we saw him tweet about Roger Stone and seem to be encouraging Roger Stone not to cooperate with federal investigators," Abramson said. "So there's a real concern here about both obstruction and witness tampering." Stone, Trump's former campaign advisor, is expected to be interviewed by the special counsel about his contact with WikiLeaks during the campaign. On ABC's "This Week" on Sunday, Stone said he would not testify against the president. In a Monday tweet, Trump approvingly quoted Stone as saying "I will never testify against Trump." He added: "Nice to know that some people still have 'guts!'" Abramson said he expects Trump's legal jeopardy to only increase. "I think what we should expect is that things will continue to get worse and worse," Abramson said. "This will get closer to the president. It will go into his family and his top aides, and I think that with every day that he tweets he creates the risk of additional charges of obstruction and witness tampering." For full interview [click here](https://cheddar.com/videos/things-are-only-going-to-get-worse-for-president-trump-says-proof-of-collusion-author-seth-abramson).

Share:
More In Politics
Trump suggests canceling Xi meeting and threatens more tariffs after China restricts key exports
President Donald Trump says “there seems to be no reason” to meet with Chinese leader Xi Jinping as part of an upcoming trip to South Korea after China restricted exports of rare earths needed for American industry. The Republican president suggested Friday he was looking at a “massive increase” of import taxes on Chinese products in response to Xi’s moves. Trump says one of the policies the U.S. is calculating is "a massive increase of Tariffs on Chinese products coming into the United States." A monthslong calm on Wall Street was shattered, with U.S. stocks falling on the news. The Chinese Embassy in Washington hasn't responded to an Associated Press request for comment.
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More